home / stock / oncs / oncs news

ONCS News and Press, OncoSec Medical Incorporated From 08/05/20

Stock Information
Company Name: OncoSec Medical Incorporated
Stock Symbol: ONCS
Market: NASDAQ
Menu
ONCS ONCS Quote ONCS Short ONCS News ONCS Articles ONCS Message Board
Get ONCS Alerts

News, Short Squeeze, Breakout and More Instantly...
ONCS - LD Micro Announces Preliminary List of Presenters for the LD-500

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. "For the first time in ten years, we were unable to host our mid-year conference, which ...
ONCS - OncoSec promotes Lellie Malloy Foerter as COO

Kellie Malloy Foerter, previously Chief Clinical Development Officer of OncoSec Medical Incorporated (NASDAQ: ONCS )  has been promoted as Chief Operating Officer, effective immediately. More news on: OncoSec Medical Incorporated, Healthcare stocks news, Read more ...

ONCS - OncoSec Appoints Kellie Malloy Foerter as Chief Operating Officer

PENNINGTON, N.J. and SAN DIEGO , July 27, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral DNA–based cancer immunotherapies, today announced that Kellie Malloy Foerter , previously Chief...

ONCS - VXRT, ONCS, CLSN and FUV among midday movers

Gainers: Equillium (NASDAQ: EQ )  +220% . More news on: Equillium, Inc., electroCore, Inc., WiMi Hologram Cloud Inc., Stocks on the move, , Read more ...

ONCS - OncoSec's Novel COVID-19 Vaccine Candidate Featured in 'Straight Talk' Program by NBC TV in Portland, Oregon

PENNINGTON, N.J. and SAN DIEGO , July 13, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral DNA–based cancer immunotherapies, today announced the promising potential of its novel DNA–e...

ONCS - OncoSec to be Featured in "Grand Rounds: a Webinar in Biotech and Specialty Pharma," Webinar Hosted by Alliance Global Partners

PENNINGTON, N.J. and SAN DIEGO , July 9, 2020 /PRNewswire/ --  OncoSec Medical Incorporated (the "Company" or "OncoSec") (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced the Company will be featured in a live webinar, "Grand Roun...

ONCS - OncoSec Set to Join Russel Microcap® Index

PENNINGTON, N.J. and SAN DIEGO , June 24, 2020 /PRNewswire/ --  OncoSec Medical Incorporated (the "Company" or "OncoSec") (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced the Company is set to join the Russell Microcap ® In...
ONCS - OncoSec Presents Two Late-Breaking Abstracts on TAVO-PLUS at the American Association for Cancer Research (AACR) Virtual Annual Meeting II

-New Data Highlights the Flexibility of OncoSec's Therapeutic Platform to Enable Greater Anti-Tumor Activity with the Next-Generation TAVO PLUS  IL-12 Plasmid PENNINGTON, N.J. and SAN DIEGO , June 22, 2020 /PRNewswire/ --  OncoSec Medical Incorporated (the "Company" or "On...

ONCS - OncoSec Expands KEYNOTE-890 Trial into First-Line Metastatic Triple Negative Breast Cancer (mTNBC) with TAVO(TM) and KEYTRUDA® Plus Chemotherapy

PENNINGTON, N.J. and SAN DIEGO , June 9, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced that, based upon tumor regression and associated clinical resp...

ONCS - OncoSec to Present at Virtual Summer Investor Summit

PENNINGTON, N.J. and SAN DIEGO , June 4, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor , President and Chief Executive Offic...
Previous 10 Next 10